OABI
OABI
NASDAQ · Life Sciences Tools & Services

Omniab Inc

$5.07
+0.08 (+1.60%)
As of Oct 3, 2:16 AM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +8.1% upside
Low Target $3.95
Average Target $5.48
High Target $7.31
Current Price $5.07
Current
$5.07
Target
$5.48
$3.95 $5.48 avg $7.31
Scenario Analysis
Bear Case
$3.95
-22.1%
Low target
Base Case
$5.48
+8.1%
Avg target
Bull Case
$7.31
+44.2%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$5.43
-6.6% from high
52-Week Low
$1.30
+290.0% from low
Target vs 52W High
$5.48
+0.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 36 81% $369.21 -43.6%
DHR
Danaher Corp
Strong Buy 32 84% $158.11 -26.1%
A
Agilent Technologies Inc
Strong Buy 30 77% $64.69 -61.4%
WAT
Waters Corp
Buy 31 65% $189.60 -55.4%
IQV
Iqvia Holdings Inc
Strong Buy 28 82% $82.96 -67.9%
ILMN
Illumina Inc
Buy 28 57% $169.36 -38.0%
MTD
Mettler-Toledo International
Hold 19 53% $170.43 -88.5%
WST
West Pharmaceutical Services
Strong Buy 23 91% $136.24 -62.7%